Quetiapine Tablet, Film Coated
Product Images NDC 72789-266

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 72789-266). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789266 Label (72789266)

72789266 Label (72789266)
This is a medication warning label for Quetiapine, which can cause drowsiness and impair alertness, so it is advised not to drive or perform mental tasks requiring attention after taking it. Alcohol should also be avoided while taking this medication. It is important to keep this medication out of the reach of children. Dosage and storage instructions can be found in the package insert. The medication comes in a package of seven tablets with a lot number of H22ca3 01 and an expiration date of 08/2024. Each tablet contains 50mg of Quetiapine. For side effects, medical advice should be sought from a doctor, and side effects can also be reported to the FDA.*
FDA Label Image

Quetiapine-fig1 (Quetiapine Fig1)

Quetiapine-fig1 (Quetiapine Fig1)
This is a graph displaying the proportion of patients with relapse over time in a study of mood events (Study 7). The x-axis represents time in weeks, and the y-axis represents the percentage of patients who experienced a relapse. The graph shows two Kaplan-Meier curves, one for "uvaL" and one for "Plas LWAL." There are also numbers from 0 to 100 on the y-axis indicating the proportion of patients with relapse.*
FDA Label Image

Quetiapine-fig2 (Quetiapine Fig2)

Quetiapine-fig2 (Quetiapine Fig2)
The figure shows Kaplan-Meier curves representing the time to recurrence of a mood event in Study 8. The X-axis corresponds to the time (in weeks) and the Y-axis shows the proportion of patients with relapse. This graph could be useful in determining the probability of recurrence for patients with a mood disorder.*
FDA Label Image

Structure (Quetiapine Stru)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.